Skip to content

A CLINICAL STUDY ON THE EFFICACY OF Ayurvedic intervention IN THE MANAGEMENT OF DIABETIC MACULAR EDEMA (DME)

A Randomized Comparative Clinical Study On The Efficacy Of Mehmudgar Ras Vati With And Without Virechan Karma In The Management Of Timir W.S.R.To Diabetic Macular Edema (DME)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032803
Enrollment
60
Registered
2021-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E083- Diabetes mellitus due to underlying condition with ophthalmic complications

Interventions

Intervention1: group 1 : virechan karma & Mehmudgar ras Vati 250 mg bd will be given daily with Sukhoshana Jal for 45 days.: After Confirmation of diagnosis, firstly Deepan /Pachan Karma with Panchko

Sponsors

Dr Ankur Tripathi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in this trial through written informed consent. Patients who are 40-70 years of age from either sex. Patients having specific symptoms of prameh janya timira /D.M.E. Diagnosed cases of diabetics mellitus type2 with NPDR cases with macular edema. Good visual acuity, minimum 6/60 or better

Exclusion criteria

Exclusion criteria: Patients not willing for the present treatment. Patients having history of glaucoma and on anti glaucoma treatment. Patients below age of 40 and above 70. Patients with moderate to severe cataractous changes. Patients having proliferative and advanced diabetic retinopathy changes. Patients with any other complications of Diabetes like nephropathy and neuropathy. Visual acuity less than 6/60. Hypertensive/pregnant/diabetic mellitus type 1

Design outcomes

Primary

MeasureTime frame
improvement in Blurred Vision - Floaters - Photophobia -Visual Acuity auto refractometry / Retinoscopy -Optical Coherence Tomography (OCT Macula) -Fundoscopy Timepoint: Baseline After 3 week then After 6 week

Secondary

MeasureTime frame
to monitor fasting blood sugar post postprandial blood sugar change in Hba1cTimepoint: Baseline After 3 week then after 6 week

Countries

India

Contacts

Public ContactANKUR TRIPATHI

National institute of Ayurveda

shamsa_fiaz@yahoo.com8764009846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026